Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tanmay Bharat, a group leader at the Sir William Dunn School of Pathology, has been awarded a prestigious Lister Institute Research Prize in the 2021 funding round.

Dr Tanmay Bharat

He is one of only six researchers to secure the £250,000 grant award.

The institute views Tanmay’s research as cutting edge and the prize acknowledges both his current performance as an early-career biomedical scientist and the future potential of his research.

Tanmay’s group study how bacteria form biofilms – multicellular, organised communities that constitute one of the primary mechanisms by which bacteria evade antibiotics. Having made significant advances in studying biofilms, the laboratory has recently utilised advanced imaging and structural biology techniques to investigate the surface layers that coat most bacteria and archaea. The prize will help support the continuation of this research.

Read the full story on the Sir William Dunn School of Pathology website.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.